Concepedia

Author

David W. Kuroki

University of Minnesota

Also Known As

D W Kuroki, David W. Kuroki

7

Publications

242

Citations

6

H-Index

29

Concepts

All Affiliations

University of MinnesotaMasonic Cancer CenterUniversity of Minnesota Medical Center
DW

About

David W. Kuroki is an author at University of Minnesota specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

83

2

Cell Biology

3

3

83

3

Immunology

2

2

54

4

Natural Sciences

1

1

29

5

Cellular Physiology

1

1

29

David W. Kuroki

×

6

Publications

240

Citations

6

H-Index

YearCitations

A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma

Daniel A. Vallera, D.A. Todhunter, David W. Kuroki,

Clinical Cancer Research

2005

99

Regulation of a c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase Cascade by a Sodium-dependent Signal Transduction Pathway

David W. Kuroki, Audrey Minden, Irma Sánchez,

Journal of Biological Chemistry

1997

40

Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice

Daniel A. Vallera, D.A. Todhunter, David W. Kuroki,

Leukemia Research

2004

34

Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.

David W. Kuroki, Gary S. Bignami, Elizabeth V. Wattenberg

PubMed

1996

29

Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled Anti-CD19 Antibody

Daniel A. Vallera, Michael K. Elson, Martin W. Brechbiel,

Cancer Biotherapy and Radiopharmaceuticals

2004

20

Molecular modification of a recombinant anti-CD3ε-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model

Daniel A. Vallera, David W. Kuroki, Angela Panoskaltsis‐Mortari,

Blood

2000

18

Page 1